ReShape Lifesciences Ownership 2024 | Who Owns ReShape Lifesciences Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.04%

Insider Ownership

11.16%

Retail Ownership

88.79%

Institutional Holders

1.00

ReShape Lifesciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	17.57%	0.17%	74,583	74,583	100.00%	191,678,000	Mar 31, 2023
BLACKROCK INC.	8.03%	-	34,060	34,043	200252.94%	87,534,000	Mar 31, 2023
VANGUARD GROUP INC	4.85%	-	20,591	20,591	100.00%	52,919,000	Mar 31, 2023
STATE STREET CORP	3.07%	-	13,015	13,015	100.00%	33,449,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	1,404	47	3.46%	4,000	Mar 31, 2023
BERGANKDV WEALTH MANAGEMENT, LLC	0.06%	0.00%	275	275	100.00%	707,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	5	5	100.00%	12,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	3	-	-	8,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	8,000	Mar 31, 2023
UBS GROUP AG	0.00%	-	2	-262	-99.24%	5,000	Mar 31, 2023
TRANSAMERICA FINANCIAL ADVISORS, INC.	0.00%	0.00%	2	-	-	1,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-	-	3,000	Mar 31, 2023

ReShape Lifesciences's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 17.57% of the company's total share outstanding, currently valued at $191.68M. The top 10 institutional shareholders own together 33.92% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	17.57%	0.17%	74,583	74,583	100.00%	191,678,000	Mar 31, 2023
TRANSAMERICA FINANCIAL ADVISORS, INC.	0.00%	0.00%	2	-	-	1,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	1,404	47	3.46%	4,000	Mar 31, 2023
BERGANKDV WEALTH MANAGEMENT, LLC	0.06%	0.00%	275	275	100.00%	707,000	Mar 31, 2023
BLACKROCK INC.	8.03%	-	34,060	34,043	200252.94%	87,534,000	Mar 31, 2023
STATE STREET CORP	3.07%	-	13,015	13,015	100.00%	33,449,000	Mar 31, 2023
VANGUARD GROUP INC	4.85%	-	20,591	20,591	100.00%	52,919,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	3	-	-	8,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	5	5	100.00%	12,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	8,000	Mar 31, 2023
UBS GROUP AG	0.00%	-	2	-262	-99.24%	5,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-	-	3,000	Mar 31, 2023

The largest ReShape Lifesciences shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 74.58K shares of ReShape Lifesciences (RSLS), representing 0.17% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	17.57%	0.17%	74,583	74,583	100.00%	191,678,000	Mar 31, 2023
BLACKROCK INC.	8.03%	-	34,060	34,043	200252.94%	87,534,000	Mar 31, 2023
VANGUARD GROUP INC	4.85%	-	20,591	20,591	100.00%	52,919,000	Mar 31, 2023
STATE STREET CORP	3.07%	-	13,015	13,015	100.00%	33,449,000	Mar 31, 2023
BERGANKDV WEALTH MANAGEMENT, LLC	0.06%	0.00%	275	275	100.00%	707,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	1,404	47	3.46%	4,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	5	5	100.00%	12,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-	-	3,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	8,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	3	-	-	8,000	Mar 31, 2023
TRANSAMERICA FINANCIAL ADVISORS, INC.	0.00%	0.00%	2	-	-	1,000	Mar 31, 2023
UBS GROUP AG	0.00%	-	2	-262	-99.24%	5,000	Mar 31, 2023

As of Mar 31 2023, ReShape Lifesciences's largest institutional buyer is SABBY MANAGEMENT, LLC. The company purchased 74.58K stocks of RSLS, valued at $191.68M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.00%	-	2	-262	-99.24%	5,000	Mar 31, 2023
TRANSAMERICA FINANCIAL ADVISORS, INC.	0.00%	0.00%	2	-	-	1,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	3	-	-	8,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	8,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-	-	3,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	5	5	100.00%	12,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	1,404	47	3.46%	4,000	Mar 31, 2023
BERGANKDV WEALTH MANAGEMENT, LLC	0.06%	0.00%	275	275	100.00%	707,000	Mar 31, 2023
STATE STREET CORP	3.07%	-	13,015	13,015	100.00%	33,449,000	Mar 31, 2023
VANGUARD GROUP INC	4.85%	-	20,591	20,591	100.00%	52,919,000	Mar 31, 2023
BLACKROCK INC.	8.03%	-	34,060	34,043	200252.94%	87,534,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	17.57%	0.17%	74,583	74,583	100.00%	191,678,000	Mar 31, 2023

As of Mar 31 2023, ReShape Lifesciences's biggest institutional seller is UBS GROUP AG. The company sold -0.26K shares of RSLS, valued at $5.00K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	17.57%	0.17%	74,583	74,583	100.00%	191,678,000	Mar 31, 2023
VANGUARD GROUP INC	4.85%	-	20,591	20,591	100.00%	52,919,000	Mar 31, 2023
STATE STREET CORP	3.07%	-	13,015	13,015	100.00%	33,449,000	Mar 31, 2023
BERGANKDV WEALTH MANAGEMENT, LLC	0.06%	0.00%	275	275	100.00%	707,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	5	5	100.00%	12,000	Mar 31, 2023

ReShape Lifesciences's largest new institutional shareholder by number of shares is SABBY MANAGEMENT, LLC, purchased 74.58K shares, valued at $191.68M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

ReShape Lifesciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
T. Rowe Price Index Trust, Inc.	0.00%	69,700	-	-	Feb 29, 2024
FIDELITY COMMONWEALTH TRUST	0.00%	3,922	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	99,748	49,874	100.00%	Dec 31, 2023
ADVANCED SERIES TRUST	0.00%	65,100	-	-	Dec 29, 2023

ReShape Lifesciences's largest mutual fund holder by % of total assets is "T. Rowe Price Index Trust, Inc.", owning 69.70K shares, compromising 0.00% of its total assets.

ReShape Lifesciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 20	1	-
31 Dec, 19	1	-

As of 31 Mar 20, 1 institutions are holding ReShape Lifesciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 20	61	-3.17%
31 Dec, 19	63	-

ReShape Lifesciences (RSLS) has 61.00 shares outstanding as of 31 Mar 20, down -3.17% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 20	0.04%	2176.11%
31 Dec, 19	0.05%	-

As of 31 Mar 20, ReShape Lifesciences is held by 0.04% institutional shareholders, representing a 2176.11% growth compared to 31 Dec 19.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 20	-	-100.00%
31 Dec, 19	1	-

- institutional shareholders have increased their position in RSLS stock as of 31 Mar 20 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 20	1	-
31 Dec, 19	-	-

1 institutional shareholders have reduced their position in RSLS stock as of 31 Mar 20 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 20	1	-	61	-3.17%	0.04%	2176.11%	-	-100.00%	1	-
31 Dec, 19	1	-	63	-	0.05%	-	1	-	-	-

ReShape Lifesciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	108	$1.43	$154.44	23,276
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	39	$1.42	$55.38	23,237
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	118	$0.89	$105.02	23,119
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	39	$0.93	$36.27	23,080
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	131	$0.27	$35.37	22,949
Jul 19, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	106	$1.47	$155.82	23,384
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	P-Purchase	Buy	17,702	$1.52	$26.91K	23,490
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	109	$2.60	$283.40	5,982
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	96	$2.36	$226.56	5,886
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	98	$2.41	$236.18	5,788
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	48	$7.49	$359.52	6,461
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	110	$7.49	$823.97	6,351
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	157	$13.29	$2.09K	6,194
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	103	$4.25	$437.75	6,091
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	364,756	$0.17	$61.83K	332,761
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	5,144	$0.15	$778.29	327,617
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	2,213	$0.15	$333.94	325,404
Nov 10, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	5,883	$0.27	$1.60K	335,271

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	P-Purchase	Buy	17,702	$1.52	$26.91K	23,490

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 16, 2024	Schneid Yair	10 percent owner	-		Sell	-	-	-	2,461,000
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	108	$1.43	$154.44	23,276
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	39	$1.42	$55.38	23,237
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	118	$0.89	$105.02	23,119
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	39	$0.93	$36.27	23,080
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	131	$0.27	$35.37	22,949
Jul 19, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	106	$1.47	$155.82	23,384
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	109	$2.60	$283.40	5,982
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	96	$2.36	$226.56	5,886
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	98	$2.41	$236.18	5,788
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	48	$7.49	$359.52	6,461
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	110	$7.49	$823.97	6,351
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	157	$13.29	$2.09K	6,194
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	103	$4.25	$437.75	6,091
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	364,756	$0.17	$61.83K	332,761
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	5,144	$0.15	$778.29	327,617
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	2,213	$0.15	$333.94	325,404
Nov 10, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	5,883	$0.27	$1.60K	335,271

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 16, 2024	Schneid Yair	10 percent owner	-		Sell	-	-	-	2,461,000
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	108	$1.43	$154.44	23,276
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	39	$1.42	$55.38	23,237
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	118	$0.89	$105.02	23,119
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	39	$0.93	$36.27	23,080
Nov 08, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	131	$0.27	$35.37	22,949
Jul 19, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	106	$1.47	$155.82	23,384
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	P-Purchase	Buy	17,702	$1.52	$26.91K	23,490
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	109	$2.60	$283.40	5,982
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	96	$2.36	$226.56	5,886
Jul 06, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	98	$2.41	$236.18	5,788
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	48	$7.49	$359.52	6,461
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	110	$7.49	$823.97	6,351
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	157	$13.29	$2.09K	6,194
Mar 07, 2023	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	103	$4.25	$437.75	6,091
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	A-Award	Buy	364,756	-	-	697,517
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	364,756	$0.17	$61.83K	332,761
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	5,144	$0.15	$778.29	327,617
Dec 20, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	2,213	$0.15	$333.94	325,404
Nov 10, 2022	STANKOVICH THOMAS	officer	Chief Financial Officer	S-Sale	Sell	5,883	$0.27	$1.60K	335,271

The last insider sell of ReShape Lifesciences's stock was made by Schneid Yair on Jan 16 2024, selling - shares at - per share (valued at -). The last insider buy of RSLS was made by STANKOVICH THOMAS on Jul 06 2023, buying 17,702 shares at $1.52 per share (worth $26.91K).

ReShape Lifesciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	4	-
Q4 2022	1	7	14.29%
Q3 2022	-	6	-
Q2 2022	1	6	16.67%
Q1 2022	-	6	-
Q4 2021	1	6	16.67%
Q3 2021	10	3	333.33%
Q2 2021	12	17	70.59%
Q3 2020	12	-	-
Q2 2020	4	-	-
Q1 2020	5	-	-
Q4 2019	7	-	-
Q3 2019	30	-	-
Q2 2019	1	1	100.00%
Q1 2019	9	-	-
Q4 2018	1	-	-
Q3 2018	16	1	1600.00%
Q2 2018	18	-	-
Q1 2018	20	6	333.33%
Q4 2017	5	-	-

0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by ReShape Lifesciences's insiders, as of Q1 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	4	-
Q4 2022	-	7	-
Q3 2022	-	5	-
Q2 2022	1	6	16.67%
Q1 2022	-	6	-
Q4 2021	1	6	16.67%
Q3 2021	2	3	66.67%
Q2 2021	-	12	-
Q3 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	1	-	-
Q3 2019	20	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	-	-	-
Q3 2018	3	-	-
Q2 2018	-	-	-
Q1 2018	5	-	-
Q4 2017	-	-	-

As of Q1 2023, Insider owners conducted 0 open market buy trades and 4 open market sell trades of ReShape Lifesciences's stocks.

ReShape Lifesciences Peer Ownership

Ticker	Company
TNON	Tenon Medical, Inc.
NURO	NeuroMetrix, Inc.
HSCS	Heart Test Laboratories, Inc.
BBLG	Bone Biologics Corporation
TIVC	Tivic Health Systems, Inc.
INVO	INVO Bioscience, Inc.
SINT	Sintx Technologies, Inc.
NUWE	Nuwellis, Inc.
IINN	Inspira Technologies Oxy B.H.N. Ltd.
OPGN	OpGen, Inc.
TLIS	Talis Biomedical Corporation
HSDT	Helius Medical Technologies, Inc.

RSLS Ownership FAQ

Who Owns ReShape Lifesciences?

ReShape Lifesciences is owned by institutional shareholders (0.04%), insiders (11.16%), and public (88.79%). The largest institutional shareholder of ReShape Lifesciences is SABBY MANAGEMENT, LLC (17.57% of total shares) and the top mutual fund owner is T. Rowe Price Index Trust, Inc. (0.00% of total shares).

Who are the major institutional shareholders of ReShape Lifesciences?

ReShape Lifesciences's major institutional shareholders are SABBY MANAGEMENT, LLC, BLACKROCK INC., VANGUARD GROUP INC, STATE STREET CORP, and TOWER RESEARCH CAPITAL LLC (TRC). The top five shareholders own together 33.85% of the company's share outstanding.

How many ReShape Lifesciences shareholders are there?

As of Mar 2020, there are 1 institutional shareholders of ReShape Lifesciences.

What percentage of ReShape Lifesciences is owned by SABBY MANAGEMENT, LLC?

SABBY MANAGEMENT, LLC owns 74.58K shares of ReShape Lifesciences, representing 17.57% of the company's total shares outstanding, valued at $191.68M (as of Mar 2023).

What percentage of ReShape Lifesciences is owned by BLACKROCK INC?

As of Mar 2023, BLACKROCK INC holds 34.06K shares of ReShape Lifesciences (RSLS), compromising 8.03% of the company, valued at $87.53M.

What percentage of ReShape Lifesciences is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC is the third largest holder of ReShape Lifesciences. The company owns 20.59K of the company's shares outstanding (worth $52.92M).